Biostage, Inc. (BSTG) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Holliston, MA, 미국. 현재 CEO는 Junli He.
BSTG 을(를) 보유 IPO 날짜 2013-10-21, 7 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $57.82M.
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
